These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20534161)

  • 21. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of BODE index and its relationship with systemic inflammation mediated by proinflammatory biomarkers in patients with COPD.
    Khan NA; Daga MK; Ahmad I; Mawari G; Kumar S; Kumar N; Husain SA
    J Inflamm Res; 2016; 9():187-198. PubMed ID: 27920567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Serum Interleukin 6, Albumin and C-Reactive Protein in COPD Patients.
    Emami Ardestani M; Zaerin O
    Tanaffos; 2015; 14(2):134-40. PubMed ID: 26528368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status.
    Caram LM; Ferrari R; Bertani AL; Garcia T; Mesquita CB; Knaut C; Tanni SE; Godoy I
    PLoS One; 2016; 11(10):e0164290. PubMed ID: 27737010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
    Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of oxidant/antioxidant balance in COPD and non-COPD smokers.
    Aydemir Y; Aydemir Ö; Şengül A; Güngen AC; Çoban H; Taşdemir C; Düzenli H; Şehitoğulları A
    Heart Lung; 2019; 48(6):566-569. PubMed ID: 31371032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased leptin/leptin receptor pathway affects systemic and airway inflammation in COPD former smokers.
    Bruno A; Alessi M; Soresi S; Bonanno A; Riccobono L; Montalbano AM; Albano GD; Gjomarkaj M; Profita M
    J Inflamm Res; 2011; 4():51-9. PubMed ID: 22096369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased IFN-γ-producing Th17/Th1 cells and their association with lung function and current smoking status in patients with chronic obstructive pulmonary disease.
    Xu W; Li R; Sun Y
    BMC Pulm Med; 2019 Jul; 19(1):137. PubMed ID: 31349846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of chronic obstructive pulmonary disease in healthy individuals with high C-reactive protein levels by smoking status: a population-based cohort study in Korea.
    Lim SY; Zhao D; Guallar E; Chang Y; Ryu S; Cho J; Shim JY
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2037-2046. PubMed ID: 31564851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort.
    Lutter JI; Jörres RA; Welte T; Watz H; Waschki B; Alter P; Trudzinski FC; Ohlander J; Behr J; Bals R; Studnicka M; Holle R; Vogelmeier CF; Kahnert K
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2787-2798. PubMed ID: 33177816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is the COPD assessment test (CAT) effective in demonstrating the systemic inflammation and other components in COPD?
    Sarioglu N; Hismiogullari AA; Bilen C; Erel F
    Rev Port Pneumol (2006); 2016; 22(1):11-7. PubMed ID: 26534740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic inflammation during exacerbations of chronic obstructive pulmonary disease].
    Malo O; Sauleda J; Busquets X; Miralles C; Agustí AG; Noguera A
    Arch Bronconeumol; 2002 Apr; 38(4):172-6. PubMed ID: 11953269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of placenta growth factor in COPD.
    Cheng SL; Wang HC; Yu CJ; Yang PC
    Thorax; 2008 Jun; 63(6):500-6. PubMed ID: 18202163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic CD4+ and CD8+ T-cell cytokine profiles correlate with GOLD stage in stable COPD.
    Paats MS; Bergen IM; Hoogsteden HC; van der Eerden MM; Hendriks RW
    Eur Respir J; 2012 Aug; 40(2):330-7. PubMed ID: 22183488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung deposition and systemic bioavailability of dose delivered to smoker compared with non-smoker COPD subjects.
    Mohamed BME; Salah Eldin R; Salah Eldin A; Abdelrahim MEA; Hussein RRS
    Int J Clin Pract; 2021 Apr; 75(4):e13883. PubMed ID: 33278071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistency and reliability of smoking-related variables: longitudinal study design in asthma and COPD.
    Hirvonen E; Stepanov M; Kilpeläinen M; Lindqvist A; Laitinen T
    Eur Clin Respir J; 2019; 6(1):1591842. PubMed ID: 31007878
    [No Abstract]   [Full Text] [Related]  

  • 40. Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS.
    Garudadri S; Woodruff PG; Han MK; Curtis JL; Barr RG; Bleecker ER; Bowler RP; Comellas A; Cooper CB; Criner G; Dransfield MT; Hansel NN; Paine R; Krishnan JA; Peters SP; Hastie AT; Martinez FJ; O'Neal WK; Couper DJ; Alexis NE; Christenson SA
    Chest; 2019 May; 155(5):908-917. PubMed ID: 30684474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.